Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.720
+0.040 (1.09%)
Nov 22, 2024, 4:00 PM EST - Market closed
Mereo BioPharma Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -45.32 | -29.47 | -42.22 | 12.73 | -163.63 | -34.84 | Upgrade
|
| Depreciation & Amortization | 1.1 | 1.06 | 0.89 | 0.64 | 1.6 | 1.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.11 | 10.87 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.04 | -0.19 | Upgrade
|
| Stock-Based Compensation | 6.69 | 4.92 | 4.77 | 3.3 | 1.56 | 1.64 | Upgrade
|
| Other Operating Activities | 10.66 | 3.94 | -9.91 | -19.95 | 124.71 | -6.44 | Upgrade
|
| Change in Accounts Receivable | - | - | - | -0.59 | 0.14 | -0.94 | Upgrade
|
| Change in Accounts Payable | 0.29 | -1.26 | 0.62 | -1.26 | -3.55 | -6.73 | Upgrade
|
| Change in Other Net Operating Assets | -3.62 | -0.33 | -2.97 | - | - | - | Upgrade
|
| Operating Cash Flow | -30.2 | -21.13 | -48.82 | -5.24 | -28.34 | -45.93 | Upgrade
|
| Capital Expenditures | - | - | -0.01 | -0.54 | -0.02 | -0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -0.35 | 10.07 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.7 | -0.42 | 2 | 0.11 | 1.82 | - | Upgrade
|
| Investment in Securities | - | - | - | - | - | 32.87 | Upgrade
|
| Other Investing Activities | - | - | - | 0 | 0.04 | 0.38 | Upgrade
|
| Investing Cash Flow | -0.7 | -0.42 | 1.99 | -0.42 | 1.5 | 43.3 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 44.38 | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.19 | - | -0.69 | -21.89 | -2.21 | Upgrade
|
| Net Debt Issued (Repaid) | - | -3.19 | - | -0.69 | 22.49 | -2.21 | Upgrade
|
| Issuance of Common Stock | 47 | 11.61 | - | 78.58 | 20.14 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -1 | Upgrade
|
| Other Financing Activities | -0.81 | -0.44 | 0.2 | -0.23 | -7.89 | -2.5 | Upgrade
|
| Financing Cash Flow | 46.19 | 7.97 | 0.2 | 77.65 | 34.74 | -5.71 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.71 | 2.82 | -12.58 | -1.17 | -0.77 | -0.35 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 17.99 | -10.76 | -59.22 | 70.83 | 7.12 | -8.7 | Upgrade
|
| Free Cash Flow | -30.2 | -21.13 | -48.83 | -5.77 | -28.36 | -45.95 | Upgrade
|
| Free Cash Flow Margin | -3020.30% | -211.32% | - | -15.83% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -0.16 | -0.40 | -0.05 | -0.42 | -2.57 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.88 | 0.02 | - | 2.9 | 1.74 | Upgrade
|
| Cash Income Tax Paid | - | -1.34 | 1.88 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -20.09 | -14.17 | -32.74 | -6.7 | -18.8 | -28.48 | Upgrade
|
| Unlevered Free Cash Flow | -19.25 | -12.37 | -30.13 | -4.34 | -14.91 | -25.6 | Upgrade
|
| Change in Net Working Capital | 0.78 | 0.98 | 4.83 | -5.22 | -3.61 | 4.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.